Funding Opportunities for FY19 DoD Kidney Cancer Research Program

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”

At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community.

November 07, 2025

By Jacquelyn Cobb and Paul Goldberg

Guest Editorial

How next generation sequencing is powering the shift to more accessible—and comprehensive—cancer care

Research has shown that delivering tumor profiling results to cancer patients prior to initiation of treatment and connecting patients harboring an actionable oncogenic mutation with the right targeted therapy can deliver superior patient outcomes. To fulfill this promise of precision medicine, we need to ensure more targeted therapies are available to patients who need them. Fortunately, this work is well underway. xxx:more

November 07, 2025

By Kathy Davy

City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure

As we mark Lung Cancer Awareness Month, it is a time to acknowledge that screening and prevention are vital, and equally crucial is ensuring that patients have access to state-of-the-art care and research. Herein, I spotlight some of the transformative work underway at City of Hope.

November 07, 2025

By Ravi Salgia

Cancer Policy

HHS (again) postpones USPSTF meeting

The U.S. Preventative Services Task Force has postponed its November meeting due to the federal government shutdown.

November 07, 2025

By Claire Marie Porter

Cancer Policy

Zongertinib, dostarlimab chosen in second batch of National Priority Vouchers recipients

FDA announced six additional awardees under the Commissioner’s National Priority Voucher pilot program, which aims to accelerate review time for applications that are deemed to be advancing U.S. “national priorities” (The Cancer Letter, Oct. 24, June 20, 2025).

November 07, 2025

By Jacquelyn Cobb

Cancer Policy

American Academy of Pediatrics: Leucovorin is not recommended for routine use in autistic children

The American Academy of Pediatrics does not recommend the routine use of leucovorin (folinic acid) for autistic children, according to the interim guidance issued by the physician group Oct. 31.

November 07, 2025

By Sara Willa Ernst

Funding Opportunities for FY19 DoD Kidney Cancer Research Program

YOU MAY BE INTERESTED IN

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”

How next generation sequencing is powering the shift to more accessible—and comprehensive—cancer care

City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure

HHS (again) postpones USPSTF meeting

Zongertinib, dostarlimab chosen in second batch of National Priority Vouchers recipients

American Academy of Pediatrics: Leucovorin is not recommended for routine use in autistic children

Renew today!

Subscriber content

Never miss an issue!

Login

Funding Opportunities for FY19 DoD Kidney Cancer Research Program

YOU MAY BE INTERESTED IN

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery“This has always made our environment stronger, not weaker.”

How next generation sequencing is powering the shift to more accessible—and comprehensive—cancer care

City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure

HHS (again) postpones USPSTF meeting

Zongertinib, dostarlimab chosen in second batch of National Priority Vouchers recipients

American Academy of Pediatrics: Leucovorin is not recommended for routine use in autistic children

Never miss an issue!

Login

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”